Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 3, Issue 1
February 2026
In Progress
Blood Neoplasia Cover Image for Volume 3, Issue 1

Volume 3 Issue 1 | Blood Neoplasia | American Society of Hematology

CLINICAL TRIALS AND OBSERVATIONS

Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AML
Clinical Trials & Observations
Jayanshu Jain,Kelly Pugh,Shivani Handa,Kaitlyn M. Dvorak-Kornaus,Qiuhong Zhao,Roland B. Walter,Rachel Cook,Jennifer Saultz,Ronan Swords,Junyang Li,George S. Laszlo,Nicole R. Grieselhuber,Alice S. Mims,Karilyn T. M. Larkin,Kieran Sahasrabudhe,James S. Blachly,Gregory K. Behbehani,Ann-Kathrin Eisfeld,Meixiao Long,Andrew Srisuwananukorn,Kristin L. Koenig,Uma Borate
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

MYELOID NEOPLASIA

Targeting dysregulated epigenetic and transcription factor networks in KMT2A-rearranged AML using iPSC models
Anna Palau,Jonas Thier,Aonghus Naughton,Andrew Tae-Jun Kwon,David Cabrerizo Granados,Sophia Hofmann,Bogumił Kaczkowski,Xiangfu Zhong,Sören Lehmann,Erik Arner,Vanessa Lundin,Andreas Lennartsson
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

RESEARCH LETTER

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade
Reid W. Merryman,Justin Kline,Robert A. Redd,Harrison Olszewski,Emma Welsh,Kathleen Pfaff,Hannah Lee,Mikaela McDonough,Inhye E. Ahn,Jennifer R. Brown,Jennifer L. Crombie,Matthew S. Davids,David C. Fisher,Eric D. Jacobsen,Caron A. Jacobson,Austin I. Kim,Oreofe O. Odejide,Erin Michelle Parry,Christine E. Ryan,Margaret A. Shipp,Philippe Armand,Scott Rodig,Jeremy S. Abramson,Ann S. LaCasce
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

TRANSLATIONAL RESEARCH

Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment response
Anna Maria Corsale,Mojtaba Shekarkar Azgomi,Emilia Gigliotta,Marta Di Simone,Paola Pacelli,Francesca Cioffi,Elena Bestoso,Donatella Raspadori,Alessandro Gozzetti,Antonio Solimando,Paula Tabares,Andreas Beilhack,Maria Speciale,Giusy Corsale,Miriam Sciortino,Cristina Aquilina,Fulvio Brucato,Michele Cea,Renato Zambello,Francesca Garofano,Marta Biondo,Francesca Buffa,Nadia Caccamo,Francesco Dieli,Serena Meraviglia,Sergio Siragusa,Cirino Botta
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
All Issues

Advertisement intended for health care professionals

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 

Advertisement intended for health care professionals

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals